TINAVI Medical Technologies Co., Ltd. (688277.SS)
CNY 11.63
(-2.19%)
CNY 11.63
(-2.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -102.67 Million CNY | 0.73% |
| 2022 | -87.15 Million CNY | -62.67% |
| 2021 | -59.64 Million CNY | 1.19% |
| 2020 | -51.46 Million CNY | -74.63% |
| 2019 | -27.49 Million CNY | -272.9% |
| 2018 | -1.72 Million CNY | 114.26% |
| 2017 | 17.7 Million CNY | 127.25% |
| 2016 | -34.89 Million CNY | -33.14% |
| 2015 | -26.12 Million CNY | -53.77% |
| 2014 | -17.37 Million CNY | -1666.97% |
| 2013 | -1.98 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -12.92 Million CNY | 95.68% |
| 2024 Q2 | -41.12 Million CNY | -1987.95% |
| 2024 Q3 | -34.56 Million CNY | 15.37% |
| 2023 Q3 | -42.45 Million CNY | 13.05% |
| 2023 Q4 | -45.95 Million CNY | -8.26% |
| 2023 FY | - CNY | 0.73% |
| 2023 Q1 | -1.22 Million CNY | 97.31% |
| 2023 Q2 | -48.82 Million CNY | -3898.17% |
| 2022 Q1 | -35.39 Million CNY | -40.11% |
| 2022 Q4 | -45.37 Million CNY | 0.63% |
| 2022 FY | - CNY | -62.67% |
| 2022 Q3 | -45.66 Million CNY | -174.32% |
| 2022 Q2 | -16.64 Million CNY | 52.98% |
| 2021 Q1 | -27.35 Million CNY | -1877.31% |
| 2021 Q3 | -27.51 Million CNY | -74.54% |
| 2021 Q4 | -25.26 Million CNY | 8.19% |
| 2021 FY | - CNY | 1.19% |
| 2021 Q2 | -15.76 Million CNY | 42.38% |
| 2020 Q1 | -21.19 Million CNY | -135.27% |
| 2020 Q2 | -25.66 Million CNY | -21.1% |
| 2020 Q3 | -21.7 Million CNY | 15.42% |
| 2020 FY | - CNY | -74.63% |
| 2020 Q4 | -1.38 Million CNY | 93.63% |
| 2019 Q2 | -49.7 Million CNY | -88.91% |
| 2019 FY | - CNY | -272.9% |
| 2019 Q4 | 60.08 Million CNY | 323.17% |
| 2019 Q3 | -26.92 Million CNY | 45.84% |
| 2019 Q1 | -26.31 Million CNY | 0.0% |
| 2018 FY | - CNY | 114.26% |
| 2018 Q1 | -7.07 Million CNY | -206.96% |
| 2018 Q2 | -7.07 Million CNY | 0.0% |
| 2017 Q3 | 6.61 Million CNY | 1030.31% |
| 2017 Q2 | -711.46 Thousand CNY | 0.0% |
| 2017 FY | - CNY | 127.25% |
| 2017 Q1 | -711.46 Thousand CNY | 93.04% |
| 2017 Q4 | 6.61 Million CNY | 0.0% |
| 2016 Q3 | -9.61 Million CNY | -20.21% |
| 2016 Q1 | -7.99 Million CNY | -12.88% |
| 2016 FY | - CNY | -33.14% |
| 2016 Q4 | -10.21 Million CNY | -6.28% |
| 2016 Q2 | -7.99 Million CNY | -0.0% |
| 2015 FY | - CNY | -53.77% |
| 2015 Q2 | -5.92 Million CNY | 0.0% |
| 2015 Q1 | -5.92 Million CNY | 0.0% |
| 2015 Q3 | -5.62 Million CNY | 5.01% |
| 2015 Q4 | -7.08 Million CNY | -25.86% |
| 2014 FY | - CNY | -1666.97% |
| 2013 FY | - CNY | 0.0% |